Retatrutide Study Explores Dose Escalation in Obesity Without Diabetes | Retatrutide News

The study investigates Retatrutide's efficacy and safety in obese individuals without diabetes. It is not recruiting and will last about 113 weeks.
Clinical Trials · October 11, 2026